Kit Products (Ex-US)

Developed to provide reliable information

Our ultra-sensitive OncoBEAM™ and Plasma-SeqSensei Kit products are developed to provide reliable molecular information for timely and non-invasive treatment selection, molecular monitoring and enhanced prediction of resistance to therapy.

Depending on the clinical issue, clinicians can choose between different available kits based on the highly sensitive technologies BEAMing (digital PCR) or SafeSEQ (NGS), which can be run on-site in clinically validated laboratories. For analysis only a simple blood draw is needed.

Kit Products
13

Focused and flexible

genomic coverage allows for ultra-high sensitivity and reduced costs.

23

No molecule left behind

Our technology is optimized to ensure low-frequency mutant molecule (<0.05%) detection with high specificity.

33

Customizable panels

Designed for our BioPharma partners, to rapidly include or exclude markers to maximize test performance and costs.

OncoBEAM™ Kits (EX-US)

Our digital PCR-based OncoBEAM™ Kits can be used to identify and select patients, which are suitable for cancer-specific therapy. Different Kits for Lung cancer and Coloractal cancer are available.

Plasma-SeqSensei™ Kits (EX-US)

Plasma-SeqSensei Kits are SafeSeq NGS liquid biopsy solutions designed to detect genomic alterations and characterized hotspot regions responsible for clinically relevant targets.

News & Events

The latest

Visit our resource center

Visit our resource center